Benzaclin - 0066-0494-55 - (Clindamycin phosphate and benzoyl peroxide)

Alphabetical Index


Drug Information of Benzaclin

Product NDC: 0066-0494
Proprietary Name: Benzaclin
Non Proprietary Name: Clindamycin phosphate and benzoyl peroxide
Active Ingredient(s): 50; 10    mg/g; mg/g & nbsp;   Clindamycin phosphate and benzoyl peroxide
Administration Route(s): TOPICAL
Dosage Form(s): GEL
Coding System: National Drug Codes(NDC)

Labeler Information of Benzaclin

Product NDC: 0066-0494
Labeler Name: Dermik Laboratories
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA050756
Marketing Category: NDA
Start Marketing Date: 20001221

Package Information of Benzaclin

Package NDC: 0066-0494-55
Package Description: 1 BOTTLE, PUMP in 1 CARTON (0066-0494-55) > 50 g in 1 BOTTLE, PUMP

NDC Information of Benzaclin

NDC Code 0066-0494-55
Proprietary Name Benzaclin
Package Description 1 BOTTLE, PUMP in 1 CARTON (0066-0494-55) > 50 g in 1 BOTTLE, PUMP
Product NDC 0066-0494
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Clindamycin phosphate and benzoyl peroxide
Dosage Form Name GEL
Route Name TOPICAL
Start Marketing Date 20001221
Marketing Category Name NDA
Labeler Name Dermik Laboratories
Substance Name BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Strength Number 50; 10
Strength Unit mg/g; mg/g
Pharmaceutical Classes Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient]

Complete Information of Benzaclin


General Information